| LGRCX | RGACX | LGRCX / RGACX | |
| Total Expense Ratio | 1.66 | 0.93 | 178% |
| Annual Report Gross Expense Ratio | 1.67 | 0.93 | 180% |
| Fund Existence | 22 years | 24 years | - |
| Gain YTD | 12.239 | 8.821 | 139% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 18.5B | 339B | 5% |
| Annual Yield % from dividends | 0.00 | 0.07 | - |
| Returns for 1 year | 7.89 | 5.45 | 145% |
| Returns for 3 years | 92.45 | 63.36 | 146% |
| Returns for 5 years | 27.89 | 20.43 | 137% |
| Returns for 10 years | 139.70 | 92.34 | 151% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBBI | 52.28 | 0.15 | +0.29% |
| BondBloxx BBB Rated 5-10 Yr Corp Bd ETF | |||
| EWP | 53.92 | 0.12 | +0.22% |
| iShares MSCI Spain ETF | |||
| OPPE | 51.33 | 0.10 | +0.20% |
| WisdomTree European Opportunities ETF | |||
| DCRE | 51.84 | 0.01 | +0.02% |
| DoubleLine Commercial Real Estate ETF | |||
| WDNA | 18.05 | N/A | N/A |
| WisdomTree BioRevolution ETF | |||